Patents 22show all

  • 16
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 10
    A61B - Diagnosis
  • 2
    B01L - Chemical or physical laboratory apparatus for general use
  • 2
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms

Clinical Trials 3show all

2Phase 31N/A

SEC Filings show all


165
8-K

45
10-Q

15
10-K

7
D

1
S-1

Contact Information

San Diego, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2011-07-12$14,153,846$14,153,846Equity, Option to Acquire, Security to be Acquired
2011-06-27$2,323,710$2,323,710Equity, Option to Acquire
2011-04-19$199,999$199,999Equity
2010-01-21$5,000,000$1,743,989Equity
2009-09-10$1,749,900$1,749,900Debt, Option to Acquire
2008-10-20Unknown Unknown Other (Paper Filing)

Key Executives

  • Elias Vamvakas
    Executive Officer, Director
  • Thomas N Davidson
    Director
  • Richard L Lindstrom
    Director
  • Adrienne Graves
    Director
  • Donald Rindell
    Director
  • Anthony Altig
    Director
  • William G Dumencu
    Executive Officer
  • Robert Alan Walder
    Executive Officer
  • Adrienne L Graves
    Director
  • Thomas Davidson, Jr.
    Director
  • Richard L. Lindstrom
    Director
  • Adrienne L. Graves
    Director
  • William Dumencu
    Executive Officer
  • Robert Walder
    Executive Officer
  • Paul Karpecki
    Director
  • Brock Wright
    Director
  • William G. Dumencu
    Executive Officer